Other adverse events associated with anti-CD33 CAR-T cells included grade 3 tumor lysis syndrome, grade 2 mucositis, and grade 1 tachycardia in one patient; the second patient developed grade 2 intermittent orthostatic hypotension, grade 2 increased bilirubin and grade 3 increased alanine aminotransferase (ALT), and aspartate aminotransferase (AST). Here, GPT is linked to Tumor Lysis Syndrome.